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Abstract. Signal-dependent transport of proteins into 
the nucleus is a multi-step process mediated by nuclear 
pore complexes and cytosolic transport factors. One of 
the cytosolic factors, Ran, is the only GTPase that has a 
characterized role in the nuclear import pathway. We 
have used a mutant form of Ran with altered nucle- 
otide binding specificity to investigate whether any 
other GTPases are involved in nuclear protein import. 
D125N Ran (XTP-Ran) binds specifically to xan- 
thosine triphosphate (XTP) and has a greatly reduced 
affinity  for GTP, so it is no longer sensitive to inhibition 
by nonhydrolyzable analogues of GTP such as gua- 
nosine 5'-O-(3-thiotriphosphate) (GTP~/S). Using in 
vitro transport assays, we have found that nuclear im- 
port supported by XTP-Ran is nevertheless inhibited 
by the addition of non-hydrolyzable GTP analogues. 
This in conjunction with the properties of the inhibitory 
effect indicates that at least one additional GTPase is 
involved in the import process. Initial characterization 
suggests that the inhibited GTPase plays a direct role in 
protein import and could be a component of the nu- 
clear pore complex. 
M 
OLECULAR transport between the nucleus and cy- 
toplasm plays a fundamental role in eukaryotic 
cell metabolism. It takes place  through nuclear 
pore complexes (NPCs) 1, large (~125 MD) supramolecular 
structures that span the nuclear envelope (for reviews see 
Pant6  and  Aebi,  1993; Rout  and  Wente,  1994; Davis, 
1995). Ions, metabolites, and small  macromolecules can 
cross NPCs by passive diffusion through aqueous channels 
(Paine et al., 1975; Peters, 1986). However, most proteins 
and RNAs are too large to diffuse across NPCs at physio- 
logically  significant  rates,  and  are  instead  transported 
through  a  gated  channel  by  temperature-  and  energy- 
dependent mechanisms  (for reviews see Fabre and Hurt, 
1994; Melchior and Gerace, 1995). 
The  best-characterized pathway of nucleocytoplasmic 
transport  is  protein  import  into  the  nucleus.  Import is 
specified  by  nuclear  localization  signals  (NLSs),  which 
usually consist  of short stretches of predominantly basic 
amino acids in a single or bipartite motif (for review see 
Dingwall and Laskey, 1991). The import pathway involves 
binding  of NLS-containing proteins  to  the  cytoplasmic 
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side of the NPC and then movement over a distance  of 
>100 nm during translocation into the nucleus.  It is cur- 
rently envisaged  as a multi-step process,  which requires 
the activity of both cytosolic transport factors and NPC 
proteins (Melchior and Gerace, 1995). Significant progress 
has been made recently in the identification and character- 
ization of components of the nuclear import machinery, 
but it is likely that many more remain to be discovered. 
A  number of insights  into the mechanism of nuclear 
protein import have been obtained from in vitro transport 
assays (Melchior and Gerace, 1995). The most frequently 
used assay contains mammalian cells permeabilized with 
digitonin and supplemented with exogenous cytosol (Adam 
et al., 1990). Biochemical studies using such assays have so 
far led to the identification of five cytosolic transport fac- 
tors that are highly conserved from yeast to mammalian 
cells: the NLS receptor (importin et, karyopherin ct, Srplp) 
(Adam and Gerace, 1991; Yano et al., 1992; G0rlich et al., 
1994; Imamoto et al., 1995b; Moroianu et al., 1995a; Weis 
et al., 1995), p97 (importin 13, karyopherin 13) (Adam and 
Adam, 1994; Chi et al., 1995; Enekel et al., 1995; Imamoto 
et al., 1995a; G6rlich  et al., 1995; Radu et al., 1995), hsp/ 
hsc70 (Imamoto et al., 1992; Shi and Thomas, 1992), NTF2 
(pl0, ppl5) (Moore and Blobel, 1994; Paschal and Gerace, 
1995), and the small GTPase Ran (Melchior et al., 1993, 
1995a; Moore and Blobet,  1993). Characterization of the 
role of these cytosolic  factors in transport has led to a 
working model of the nuclear import pathway (Melchior 
and Gerace, 1995). In this model, the NLS receptor inter- 
acts  with NLS-containing proteins in the cytoplasm and 
then, in conjunction with p97, mediates their interaction 
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plasmic  site  close  to  the  initial region  of NLS-protein 
binding, and is  thought to  act as  a  molecular switch to 
commit  the  receptor  complex  to  subsequent  transport 
steps.  NTF2  is  not required  for the  initial binding step 
(Moore and Blobel, 1994; Paschal and Gerace, 1995), and 
may regulate downstream interactions with NPC proteins. 
Translocation into the nucleus is thought to involve step- 
wise movement of the receptor complex across the NPC, 
followed by release into the nucleoplasm. 
In contrast to the cytosolic transport factors, relatively 
little is known about the role of NPC proteins in the im- 
port pathway. For example, the composition and function 
of the central gated channel remains obscure. However, 
one group of NPC proteins (nucleoporins) that appears to 
be directly involved in transport is those containing multi- 
ple  dispersed  FG  (Phe,  Gly)  repeats  (Pant6  and  Aebi, 
1993; Rout and Wente, 1994; Davis, 1995). In mammalian 
cells these proteins are modified with O-linked N-acetyl- 
glucosamine and bind to the lectin wheat germ agglutinin 
(Finlay et al., 1987; Holt et al., 1987). The first indication 
that the FG repeat proteins play a role in nuclear import 
came from the observations that wheat germ agglutinin and 
specific antibodies inhibit protein import in intact cells and 
in vitro (Finlay et al.,  1987; Yoneda et al.,  1987; Dabau- 
valle et al., 1988a,b; Featherstone et al., 1988; Adam et al., 
1990). Subsequently, FG repeat proteins have been shown 
to interact directly with several cytosolic transport factors, 
including NTF2  (Paschal and  Gerace,  1995),  Ran  (Mel- 
chior et al., 1995a; Wu et al., 1995; Yokoyama et al., 1995), 
and p97  (Moroianu et al., 1995b).  FG repeat proteins are 
found on both the nucleoplasmic and cytoplasmic sides of 
the NPC (Pant6 and Aebi, 1994; Rout and Wente, 1994; 
Davis, 1995), and the receptor complex is thought to inter- 
act sequentially with several of these proteins as it crosses 
the NPC (for discussion see Melchior and Gerace, 1995). 
GTPases are involved in a wide variety of cellular pro- 
cesses, including vesicular transport in the secretory path- 
way, protein synthesis, and signal transduction (Bourne et 
al.,  1991). In most cases, the complete pathway involves 
multiple GTPases that act at different steps. From these 
precedents, it seems unlikely that Ran is the only GTPase 
involved in nuclear protein import. Additional GTPases 
could take part in, for example, targeting of the receptor 
complex to the center of the NPC or gating of the trans- 
port channel. Nonhydrolyzable analogues of GTP strongly 
inhibit nuclear protein import in permeabilized cell assays 
(Melchior et al., 1993; Moore and Blobel, 1993). This inhi- 
bition is mediated to a large extent by Ran, and results in a 
block of transport at an early step (Melchior et al., 1995a). 
In this situation, any inhibitory effects of the nonhydrolyz- 
able nucleotides on GTPases that act in later stages of the 
transport pathway would be masked by the inhibition of 
Ran.  It  would  therefore  be  very difficult to  determine 
whether any additional GTPases are involved using con- 
ventional nuclear import assays. 
To circumvent this problem, we have made use of a mu- 
tation that has previously been shown to change the nucleo- 
tide binding specificity of a number of GTPases. The con- 
served G4 region of GTPase superfamily proteins has a 
consensus sequence of NKXD, with the D  (aspartic acid) 
being particularly highly conserved (Bourne et al., 1991). 
Mutation of this residue to asparagine in several GTPases, 
including Ha-Ras (Zhong et al., 1995), Yptlp (Jones et al., 
1995),  FtsY  (Powers  and  Walter,  1995),  and  EF-Tu 
(Hwang  and  Miller,  1987; Wiejland  and  Parmeggiani, 
1993) leads to altered nucleotide binding specificity. These 
mutant proteins have a low affinity for GTP and instead 
bind to and hydrolyze xanthosine triphosphate (XTP). As 
the  structure  of the  GTP-binding region is  highly con- 
served, it seemed likely that an equivalent amino acid sub- 
stitution in Ran (D125 to N) would also change its nucle- 
otide binding specificity from GTP to XTP. 
In this study, we have constructed an XTP-binding mu- 
tant of Ran and shown that it is functional in nuclear pro- 
tein import. This mutant specifically binds to XTP rather 
than GTP, and is therefore no longer sensitive to nonhy- 
drolyzable  GTP  analogues  such  as  guanosine  5'-0-(3- 
thiotriphosphate) (GTP~/S).  We have found that nuclear 
import in assays containing XTP-Ran instead of wild-type 
is inhibited by nonhydrolyzable analogues of GTP, dem- 
onstrating that at least one additional GTPase is involved 
in the nuclear import pathway. This inhibition reduces the 
overall rate of transport and appears to be mediated by a 
factor that remains associated with cells during digitonin 
permeabilization. 
Materials and Methods 
Cells and Reagents 
Suspension cultures of human (HeLa) cells were grown in Joklik's modi- 
fied minimal essential medium (GIBCO-BRL, Gaithersburg, MD) with 
10%  newborn  calf serum (Hyclone  Laboratories,  Logan,  UT).  Nucle- 
otides  and  nucleotide  analogues were  obtained  from Sigma Immuno- 
chemicals (St. Louis, MO) (XTP, XDP, [8-3H]-XTP, Gpp(NH)p,  ATP), 
Boehringer Mannheim Biochemicals (Indianapolis, IN) (GTP, GDP, GTPvS, 
GMPPNP), or Amersham Corp. (Arlington Heights, IL) ([8-3H]GTP). Nu- 
cleotide stocks were prepared in 20 mM Hepes, pH 7.4, with an equirnolar 
concentration of Mg  2÷ and stored at -80°C. 
Expression and Purification of Wild-type 
and D125N Ran 
Recombinant wild-type Ran was expressed and purified as described pre- 
viously (Melchior et al., 1995b).  To construct the D125N mutant, the en- 
tire Ran ORF (open reading frame) was transferred as an Xbal-BamHI 
fragment from pETlld-Ran  (Melchior et al., 1993)  to pBluescript SK- 
(Stratagene Corp., La Jolla, CA). Mutagenesis was carried out using the 
clut- ung- oligonucleotide-directed method (Kunkel et al., 1987),  and the 
presence of the mutation verified by sequencing. The mutant ORF was 
then transferred back into a pETlld vector as an XbaI-BamHI fragment 
for expression in BL21(DE3) cells. The expression and purification proce- 
dures  were  similar to  those  used  for  wild-type  Ran  (Melchior  et  al., 
1995b), the only differences being that the bacterial cells were grown at 
30°C instead of 37°C to improve the solubility of the mutant protein, and 
XDP was added to 20 ~M during bacterial cell lysis and to 250 IxM during 
resolubilization of the ammonium sulfate precipitate. 
Equilibrium Binding of  Nucleotides 
The protocol used for nucleotide binding was based on those described by 
Zhong et al. (1995) and Manne et aL (1984). The binding reactions con- 
tained 0.2 I~M wild-type Ran plus 0.2 p,M [8-3H]5'-GTP (sp. act. 0.95 Ci/ 
mmol) or 0.2 I~M D125N Ran plus 0.2 p,M [8-3H]5'-XTP (sp. act. 1.2 Ci/ 
mmol) and unlabeled GTP, XTP, GTP3,S, or ATP at concentrations be- 
tween 10 -3 and 3  ×  10 -s M. Each assay contained 0.5  p,g Ran and all 
points were assayed in duplicate. The purified recombinant proteins were 
likely to be bound to GDP or XDP, so the assays also contain up to 0.2 p,M 
of these nucleotides contributed by the protein. The Ran and nucleotides 
were incubated at 30°C for 10 min in 50 mM Hepes, pH 8, 8 mM EDTA, 
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sample was then diluted with a  10-fold volume (1 ml) of ice-cold wash 
buffer (50 mM Hepes, pH 8, 150 mM KCI, 5 mM Mg(OAc)2, and 1 mM 
DTr)  and  immediately transferred  to  a  0.45  I~M  nitrocellulose  filter 
(HAWP 025 00; Millipore Corp., Bedford, MA). The unbound nucleotide 
was removed by washing with 5 ml ice-cold wash buffer. The filters were 
then dried and the bound nucleotide detected by liquid scintillation spec- 
trometry using scintillation fluid (Ecoscint A, National Diagnostics, At- 
lanta, GA). 
Preparation of Ran-depleted Cytosol 
HeLa cell cytosol was prepared  according to the method described by 
Melchior et al. (1995b) and had a typical protein concentration of 10 mg/ 
ml as determined by Bio-Rad protein assay (Bio-Rad Laboratories, Her- 
cules, CA). 
To deplete Ran from this cytosol by column fractionation, 1.5 ml cyto- 
sol was concentrated to 600 p,1 using a concentrator (centricon 10, Amicon 
Corp., Beverly, MA) and then applied in 200-p.l aliquots to either a Super- 
ose 12 or Superdex 200 column connected to an FPLC system (Pharmacia 
LKB Biotechnology Inc., Piscataway, N J). The columns were equilibrated 
in  transport  buffer  (20  mM  Hepes,  pH  7.4,  110  mM  KOAc,  2  mM 
Mg(OAc)2, 0.5 mM EGTA, 2 mM DTr, and 1 p,g/ml each of leupeptin, 
pepstatin, and aprotinin) and run at a flow rate of 0.5 ml/min. 0.5-ml frac- 
tions were collected and those that contained Ran were identified by im- 
munoblotting (see below). Ran was typically found in either six (Superose 
12) or five (Superdex 200) of the 0.5-ml fractions. The fractions lacking 
Ran were combined and concentrated to 1.5 ml (equal to the original vol 
of cytosol) in centricon-10 concentrators. The resulting cytosoI was then 
frozen in liquid N 2 and stored in aliquots at  -80°C. This procedure re- 
moved 95-97% of the cytosolic Ran, as assayed by immunoblotting of a 
dilution series, and was the method used to prepare Ran-depleted cytosol 
unless otherwise stated.  NTF2 chromatographs as  a  30-kD protein  on 
these columns, so removal of the Ran fractions also depleted significant 
amount of  the  endogenous NTF2.  Supplementary recombinant  NTF2 
(prepared using the protocol described by Paschal and Gerace, 1995) was 
therefore added to transport assays containing this eytosol, to a final con- 
centration of 12.5 ixg/ml. 
To affinity deplete Ran from cytosol by binding to RanBP1, 100  p.l of 
cytosol was incubated with 50 p,l of 7 mg/ml RanBP1 beads (see below) 
for 12 h at 4°C. The supernatant was then removed and used in transport 
assays. Although RanBP1 binds preferentially to Ran-GTP (Bischoff et 
al., 1995), which is likely to be less abundant than Ran-GDP in HeLa cyto- 
sol, incubation of the cytosol with  a  sufficiently high concentration of 
RanBP1 removed >90% of the cytosolic Ran as assayed by immunoblot- 
ting of a dilution series (Mahajan, R., and L. Gerace, unpublished obser- 
vations). Purified recombinant RanBP1 was kindly provided by Dr. Rohit 
Mahajan (Scripps Research Institute). This protein was dialyzed against 
coupling buffer (0.1  M  NaHCO3, pH 8.3,  0.5 M  NaC1) for 4 h  and then 
combined with  activated  CNBr-Sepharose 4B  beads  (Pharmacia  LKB 
Biotechnology Inc.) at 7 mg RanBP1 per 1 ml of beads. Coupling was car- 
ded out for 16 h at 4°C, after which no detectable protein remained un- 
bound (Bio-Rad protein assay). The remaining sites on the beads were 
blocked by incubation in 0.1 M Tris-HC1, pH 8, for 2 h at room tempera- 
ture. The beads were then washed in four cycles of 0.1 M NaOAc, pH 4, 
0.5 M NaC1, and 0.1 M Tris, pH 8, 0.5 M NaCI, followed by four washes in 
transport buffer before incubation with the cytosol. 
Nuclear Import Assays 
Nuclear protein import was measured using the flow cytometric assay de- 
veloped  by Paschal and Gerace  (1995).  The FITC-BSA-NLS transport 
ligand was prepared according to the method described (Paschal and Ger- 
ace, 1995),  using 25 ILl of 20 mM sulfo-SMCC and 0.3 mg of NLS peptide 
per 1 mg of FITC-BSA. 
50 ml of suspension HeLa cells (typically at a  density of 5  x  105/ml) 
were prepared for permeabilization by washing in 50 ml of ice-cold trans- 
port buffer. They were permeabilized at a  density of 5  ×  106 cells/ml in 
transport buffer containing 0.006% digitonin (Calbiochem-Behring Corp., 
San Diego, CA) by incubation for 6 min on ice, then washed again in 50 ml 
of transport buffer and resuspended at ~5  x  107 cells/ml for use in the 
transport assay. The cell concentration was determined at this stage by 
comparison of the A550 of a  1/100  dilution to a standard curve, and then 
adjusted to give the desired number of cells per 10 ~1 (2-6 ×  105). 
Transport assays (total vol 40 p.l) contained 3 x  105 permabilized cells 
per assay (unless otherwise stated), an ATP-regenerating system (1 mM 
ATP, 5 mM creatine phosphate, and 20 U/ml creatine phosphokinase), 
FITC-BSA-NLS transport  ligand  (200-800  nM)  and  HeLa cell  cytosol 
and/or recombinant transport factors. Unless otherwise stated, all assays 
also contained 1 mM XTP. When using 3 ×  105 cells per assay, a saturating 
level of transport was obtained with 10 I~1 of HeLa cytosol (final concen- 
tration 2.5 mg/ml), so an equivalent vol of Ran-depleted cytosol (deter- 
mined by comparison of the vol before and after Ran depletion) was used 
in each case. To reconstitute transport using purified recombinant factors, 
hSrpla (25 I~g/ml) and NTF2 (12.5 Ixg/ml) were added to the permeabil- 
ized cells in the presence of wild-type or XTP Ran (25 p.g/ml).  In these as- 
says, no additional stimulation of transport was obtained by adding re- 
combinant  p97  so  it  was  not  included.  The  recombinant  NTF2  was 
expressed and purified as described in Paschal and Gerace (1995). Re- 
combinant hSrplct and p97 were prepared by Tianhua Hu using expres- 
sion  constructs  provided  by  Dr.  A.  Lamond  (University of Dundee) 
(hSrpla) and Dr. S. Adam (Northwestern University School of Medicine) 
(p97), according to published protocols (Weis et al., 1995 for hSrplct; Chi 
et al., 1995 for p97). 
The assays were incubated for 30 min at 30°C (except for time courses) 
in 6-ml polystyrene tubes (2058;  Falcon Plastics, Cockeysville, MD), and 
stopped by transfer to an ice water bath. The cells were washed once in 4 ml 
of ice-cold transport buffer and resuspended in a total vol of ~0.5 ml of the 
same buffer. The fluorescence of 104 cells was measured for each sample 
using a flow cytometer (FACSort; Beckton Dickinson, San Jose, CA) and 
then the mean fluorescence of the cells in each sample was determined us- 
ing software (CellQuest; Becton Dickinson). Due to the reproducibility of 
the flow cytometric method (Paschal and Gerace, 1995),  assays were not 
normally performed in duplicate, but all the experiments shown were car- 
ried out at least three times and found to be highly reproducible. It should 
be noted that the mean fluorescence values obtained in different experi- 
ments are not necessarily directly comparable, as different batches and 
amounts of transport ligand were used and the degree of permeabilization 
of the cells can vary. 
Gel Electrophoresis, Immunoblotting, 
and Immunofluorescence 
SDS-PAGE and Western blotting were performed using standard proto- 
cols. Immunological detection of Ran involved preincubation of blots in 
PBS containing 2% dried milk powder and 0.2% Tween-20 for I  h, prob- 
ing for 1 h using anti-Ran antibodies (0.4 p,g/ml) (kindly provided by Dr. 
F. Melchior, Scripps Research Institute) in PBS +  2% dried milk powder, 
washing for 10 min in PBS and then PBS  +  0.2% Tween-20, incubation 
with  peroxidase-conjugated donkey  anti-rabbit  secondary antibody  (1: 
5,000,  Pierce,  Rockford, IL)  in PBS  +  2%  dried milk powder for  1 h, 
washing as before and then detection by chemiluminescence (ECL sys- 
tem; Amersham Corp.). Localization of Ran by immunofluorescence was 
performed  as described  previously (Melchior  et  al.,  1995a),  using the 
aforementioned affinity-purified anti-Ran antibodies. 
Results 
D125N Ran (XTP-Ran) Has Altered Nucleotide 
Binding Specificity 
The G4 region of Ran is located at residues 122-125, and 
has the sequence NKVD (Asn-Lys-Val-Asp). By analogy 
to other XTP-binding GTPase mutants, we predicted that 
replacement of Asp125 with Asn would change the nucle- 
otide binding specificity of Ran from GTP to XTP. We 
therefore constructed and purified a D125N Ran mutant. 
To compare the nucleotide binding specificity of this mu- 
tant protein with wild-type Ran, we used competition for 
binding of radiolabeled nucleotide in an EDTA-based ex- 
change assay (Fig. 1). Wild-type Ran and [3H]GTP (Fig. 1 A) 
or D125N Ran and [3H]XTP (Fig. 1 B) were incubated in 
the  presence of a  range of concentrations of unlabeled 
competitor GTP, GTP~/S, XTP, or ATP and the labeled 
nucleotide bound to Ran was measured using a filter as- 
say. The efficacy of competition by each of the unlabeled 
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Ran. As shown in Fig. 1 A, the affinity of wild-type Ran 
for XTP is approximately three orders of magnitude lower 
than its affinity for GTP or GTPgS. In contrast, the D125N 
Ran mutant (Fig. 1 B) has a high affinity for XTP, which is 
within the same order of magnitude as the affinity of wild- 
type Ran for GTP (compare the GTP curve in Fig.  1 A 
with the XTP curve in B). The D125N mutation also sig- 
nificantly reduces the affinity of Ran for GTP and GTP~/S, 
to such an extent that it no longer appears to discriminate 
between these  nucleotides and ATP. This  1,000-fold in- 
crease in affinity for XTP, and approximately reciprocal 
reduction in affinity for GTP, is similar to the effect of the 
equivalent  (Dll9N)  mutation  in  Ha-Ras  (Zhong et  al., 
1995). This single amino acid subsititution therefore appears 
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Figure 1.  Nucleotide binding specificity of wild-type and D125N 
Ran. This was determined by competition for binding of labeled 
nucleotide  to wild-type (A) and D125N Ran (B). 0.2 t~M wild- 
type Ran and [3H]GTP (A)  or D125N Ran and [3H]XTP (B) 
were incubated with a range of concentrations of unlabeled com- 
petitor GTP, GTP~/S,  XTP, or ATP in an EDTA-based exchange 
assay (see Materials and Methods). The Ran-associated nucleotide 
was collected by filter binding and detected by scintillation count- 
ing. All points represent an average of the counts from two dupli- 
cate assays. --e-, GTP; ---&--,  XTP; ---A--,  ATP; --O--, GTP~/S. 
to change effectively the nucleotide binding specificity of 
Ran, and results in a protein that binds specifically to XTP. 
Having established that D125N Ran (XTP-Ran) has al- 
tered nucleotide binding specificity, we then tested its ac- 
tivity in nuclear protein import. In permeabilized cell nu- 
clear import assays, Ran is a major rate-limiting cytosolic 
transport factor (Melchior et al., 1993). As shown in Fig. 2 A, 
addition of Ran to assays containing a subsaturating con- 
centration of cytosol results in a strong stimulation of trans- 
port. We were therefore able to test the transport activity 
of XTP-Ran by examining its ability to stimulate nuclear 
protein import. Addition of XTP-Ran stimulates nuclear 
import in an XTP-dependent manner (see Fig. 2 B). Maxi- 
mal stimulation of transport was obtained with 1 mM XTP. 
The concentrations of wild-type and XTP-Ran required to 
give a maximal stimulation of transport (in the presence of 
XTP) were the same (25 ixg/ml, data not shown), indicat- 
ing that they are of equal activity in the import assay. In a 
comparison of the time course of transport stimulation by 
wild-type and XTP-Ran (Fig. 2 C), we found that the ac- 
tivity of the mutant protein, in the presence of XTP, was 
essentially indistinguishable  from that of wild-type Ran. 
Previous studies have shown that GTP hydrolysis by Ran 
is  required  for nuclear protein  import  (Melchior et al., 
1993, 1995a;  Moore and Blobel, 1993). We therefore con- 
cluded that XTP-Ran can both bind to and hydrolyze XTP 
and, at least in the context of these in vitro transport as- 
says, perform the same function as wild-type Ran. 
Nuclear Import Supported by XTP-Ran Is Inhibited by 
Nonhydrolyzable Analogues of GTP 
Ran behaves as a cytosolic factor in permeabilized cell nu- 
clear import assays, and is efficiently released from HeLa 
cells during digitonin permeabilization. We were therefore 
able to construct assays in which nuclear import is sup- 
ported by XTP-Ran by substituting it for the endogenous 
cytosolic Ran. We used three different methods to gener- 
ate transport assays lacking endogenous Ran: removal of 
Ran from HeLa cytosol by either column fractionation or 
affinity depletion, and partial reconstitution of cytosol us- 
ing purified recombinant  transport  factors.  The column 
fractionation procedure involved separation  of cytosolic 
proteins using a  molecular sieving column and  then re- 
combination of the fractions that did not contain Ran. Af- 
finity depletion of Ran  was  accomplished by incubating 
cytosol with Sepharose-immobilized RanBP1, a small Ran- 
binding protein of as yet uncharacterized function (Couta- 
vas et al., 1993; Bischoff et al., 1995). Partial reconstitution 
of transport was achieved by adding a subset of the cur- 
rently identified cytosolic transport factors (hSrplt~, NTF2, 
and Ran) to the permeabilized cells. In all three cases, the 
Ran  activity necessary for efficient nuclear  import  was 
provided by addition of purified recombinant wild-type or 
XTP-Ran. 
Using these three different means of replacing Ran with 
the XTP-Ran mutant, we were able to test whether nu- 
clear import supported by XTP-Ran is affected by nonhy- 
drolyzable analogues of GTP (see Fig. 3). Transport assays 
containing either column fractionated cytosol (Fig. 3 A), 
RanBPl-depleted cytosol (Fig. 3 B), or hSrplot and NTF2 
(Fig. 3 C) showed only a low level of transport unless ei- 
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tional  in  nuclear  import  in 
the presence of XTP. Nuclear 
import  was  measured  using 
the  flow cytometric  method 
developed  by  Paschal  and 
Gerace (1995) (see also Mate- 
dais and Methods). (A) Stim- 
ulation of transport  by wild- 
type  Ran.  Transport  assays 
containing  a  subsaturating 
concentration  of  cytosol 
(0.9 mg/ml)  (0)  were  stimu- 
lated by adding either 25 Ixg/ 
ml wild-type Ran (+ WT Ran) 
or cytosol to a final concen- 
tration of 2.4 mg/ml (+ cyto- 
sol).  These  assays did  not 
contain added XTP. (B) XTP 
dependence  of  stimulation 
by XTP Ran. This shows a ti- 
tration of addition of XTP to 
transport  assays containing a 
subsaturating  concentration 
of cytosol  (0.9 mg/ml) plus 
25 ixg/ml  XTP-Ran,  com- 
pared with controls that lack 
added Ran. (C) Time course 
of  stimulation  by  wild-type 
and XTP-Ran. Transport  as- 
says containing a subsaturat- 
ing concentration  of cytosol 
(1.5  mg/ml) plus  25  ~g/ml 
wild-type or XTP-Ran, or no 
added  Ran,  were  incubated 
for the  indicated  times. All 
the  assays  in  C  contained 
1 mM XTP.  The  concentra- 
tion of XTP-Ran required to 
give maximal stimulation was 
determined  in  separate  ex- 
periments  (data  not shown) 
and found to be the same as 
for wild-type Ran. 
ther wild-type or XTP-Ran was added. As expected, addi- 
tion of the nonhydrolyzable GTP analogue GTP-yS to as- 
says containing wild-type Ran strongly inhibited nuclear 
import (see Fig. 3, A-C). This is consistent with the inhibi- 
tion observed with whole cytosol (Melchior et al., 1993). In 
all three cases, addition of the same concentration of GTI~S 
to assays containing XTP-Ran also resulted in a substan- 
tial  inhibition  of transport,  to  ~50--60%  of the  control 
level. Thus, using three distinct methods of replacing wild- 
type  Ran  with  XTP-Ran,  we  found  that  transport  sup- 
ported by XTP-Ran is still sensitive to inhibition by GTP~/S. 
The nuclear import pathway therefore seems to involve at 
least one other GTPase in addition to Ran. 
As an initial  characterization of this inhibition, we ex- 
amined the dose-response profile of inhibition by GTP~/S 
and the effect of other nonhydrolyzable GTP analogues 
(Fig. 4). We found that for assays containing either wild- 
type or XTP-Ran maximal inhibition was achieved by add- 
ing 50-100 IxM GTP~S. The maximum inhibition obtained 
in XTP-Ran assays was to ",~50% of control transport, while 
with wild-type Ran transport was inhibited to a greater ex- 
tent. The concentrations required to give half-maximal in- 
hibition were within the same order of magnitude (2.5 IxM 
with wild-type Ran and 5 t~M with XTP-Ran) (see Fig. 4 A), 
suggesting that the GTP~/S inhibition in XTP-Ran assays is 
mediated by a high affinity interaction. We obtained similar 
results,  i.e.,  approximately parallel  concentration depen- 
dence but a lower maximal level of inhibition with XTP-Ran 
versus wild-type,  from titrafions of GMPPNP, Gpp (NH)p, 
and GMPPCP (data not shown). Fig. 4, B and C shows a 
comparison of the inhibition obtained with maximally in- 
hibiting  concentrations  of GTP',/S,  GMPPNP,  and  Gpp 
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Figure 3.  GTP~/S inhibits  nuclear  import supported by XTP-Ran. Transport assays depleted of wild-type Ran contained  a saturation 
equivalent  (see Materials  and Methods)  of Ran-depleted HeLa cell cytosol, prepared by (A) column fractionation  and (B) affinity de- 
pletion, or (C) purified transport factors (25 ~g/ml hSrpla and 12.5 ~g/ml NTF2) instead of HeLa cell cytosol. Transport was measured 
in the absence of added Ran (white bars), in the presence of 25 i~g/ml  wild type or XTP-Ran (hatched bars) and in the presence of 25 Ixg/ 
ml wild type or XTP-Ran plus 200 ixM GTP~,S (black bars). Note that the experiments shown in parts A, B, and C were not performed 
simultaneously, so the relative mean fluorescence values do not necessarily reflect differences in the overall level of transport. 
(NH)p in assays containing either wild-type (B) or XTP- 
Ran  (C).  All  three  of these  nonhydrolyzable  GTP ana- 
logues gave a similar level of inhibition in XTP-Ran assays 
(Fig. 4  C), demonstrating that the inhibitory effect is not 
restricted to GTP~/S. 
Inhibition Is Not Mediated by Ran 
Although the endogenous Ran is efficiently removed from 
the XTP-Ran assays, a  trace amount remains in the per- 
meabilized cells (Melchior et al., 1995)  and depleted cyto- 
sol. We found that wild-type Ran has a dominant negative 
effect on GTP3,S-inhibited XTP-Ran assays, i.e., addition 
of 25  ixg/ml wild-type Ran increases the inhibition to the 
same level as observed in assays containing wild-type Ran 
alone (illustrated in Fig. 5). This raised the possibility that 
the inhibition observed in the XTP-Ran assays is caused 
by the residual wild-type Ran. It was also formally possible 
that the inhibition was mediated by the XTP-Ran binding 
inefficiently to  the  nonhydrolyzable  GTP  analogues,  al- 
though this seemed unlikely from the nucleotide binding 
data (Fig. 1) and the GTP~/S dose-response curve (Fig. 4 A). 
We therefore decided to test both of these hypotheses di- 
rectly by altering the ratio between wild-type and XTP- 
Ran in the assays. 
If the intermediate level of inhibition is due to competi- 
tion between residual wild-type Ran (which binds to the 
inhibitor)  and  the  XTP-Ran,  one would  expect  that  in- 
creasing the concentration of XTP-Ran would reduce the 
level of inhibition. Conversely, if it is caused by inefficient 
binding of GTP~/S by XTP-Ran, raising the concentration 
of XTP-Ran would increase the overall amount of inhib- 
ited Ran present and, as inhibited  (wild-type) Ran has a 
dominant  effect, might well increase  the  level of inhibi- 
tion. We therefore carried out transport assays containing 
a range of different concentrations of XTP-Ran (12.5-62.5 
i~g/ml) in the presence or absence of GTP~/S (Fig. 5 A). To 
eliminate residual cytosolic Ran from consideration in these 
experiments,  we  used  the  partially  reconstituted  system 
containing  purified  transport  factors  (see  Fig.  3  C).  As 
shown in Fig. 5 A, increasing the concentration of XTP- 
Ran over a fivefold range had no effect on the degree of 
inhibition observed in the assay. A  control assay contain- 
ing added wild-type Ran showed a greater degree of inhi- 
bition, as would be expected. Thus, the results of this titra- 
tion suggest that neither  the residual  wild-type Ran nor 
the XTP-Ran mediates the GTP',/S inhibition observed in 
the XTP-Ran assays. 
To further confirm that the residual Ran is not responsi- 
ble for the GTP~/S-dependent inhibition, we also carried 
out a titration assay involving addition of wild-type Ran to 
XTP-Ran  assays. Having previously observed that  wild- 
type Ran has a  dominant inhibitory effect, we wished to 
investigate  how  much  exogenous  wild-type  Ran  is  re- 
quired to increase the level of inhibition and compare this 
to the amount of Ran that remains in the cells. We rea- 
soned that if the amount of wild-type Ran that needs to be 
added  to  increase  the  inhibition  is  significantly  greater 
than the  amount present in the cells, this would provide 
strong evidence that the inhibition is not caused by the re- 
sidual Ran. We used purified recombinant wild-type Ran 
for these experiments, which we have found by titration 
and immunoblotting to have similar activity in nuclear im- 
port  assays  to  the  endogenous  cytosolic Ran  (data  not 
shown). Fig. 5 B shows the results of a titration of wild-type 
Ran in GTP~/S-inhibited XTP-Ran assays. As for Fig. 5 A, 
to eliminate residual cytosolic Ran from consideration we 
used  purified transport  factors to reconstitute  transport. 
We found that addition of 0.125  I~g (1/8) or less of wild- 
type Ran had no effect on the level of inhibition, while ad- 
dition of 0.2 txg (1/5) or more increased it. Immunoblotting 
of the Ran dilutions and comparison to the amount of Ran 
present in the permeabilized cells (Fig. 5  C) showed that 
the cells contained <0.0625 Ixg (1/16) of Ran. Thus, addition 
of more than twice as much wild-type Ran as was present 
in the permeabilized cells had no effect on the level of in- 
The Journal of Cell Biology, Volume 133, 1996  976 Figure  4.  Titration  of GTP~/S and  inhibition  of transport  by 
GMPPNP and Gpp(NH)p in XTP-Ran transport assays. (A) Ti- 
tration of GTP~S. Between 0 and 100 I~M GTP~S was added to 
transport assays containing  cytosol  depleted of Ran by column 
fractionation  and 25  ixg/ml wild-type  or XTP-Ran.  (B  and  C) 
Comparison of inhibition by GTP',/S, GMPPNP, and Gpp(NH)p. 
These assays contained cytosol depleted of Ran by column frac- 
tionation,  25 p.g/ml of either wild-type (B) or XTP-Ran (C) and 
200 I~M GTP~S, 250 I~M Gpp(NH)p, 500 p~M GMPPNP, or no 
GTP analogue as indicated. 
hibition.  In fact, to  double  the  level of inhibition  it  was 
necessary to  add  over 10-fold  more wild-type  Ran  than 
was present in the cells. Titration experiments performed 
with column fractionated cytosol instead of purified trans- 
port  factors gave very similar results  (data  not  shown). 
Therefore, although wild-type Ran  can have a  dominant 
competitive effect, it is highly unlikely that competition by 
residual Ran is responsible for the GTP~S inhibition ob- 
served in the XTP-Ran transport assays. 
Inhibition of Transport Does Not Lead to Accumulation 
of Ran at the Nuclear Envelope 
A  characteristic feature of inhibition of nuclear import by 
nonhydrolyzable GTP analogues is accumulation of Ran 
on the cytoplasmic side of the NPC, close to the site of ini- 
tial NLS-protein binding (Melchior et al., 1995a). This and 
other observations led to the conclusion that hydrolysis of 
GTP by Ran  is involved in  a  relatively early step of the 
transport process. Localization of XTP-Ran under inhibi- 
tion  conditions  could  potentially  be  equally  informative 
about the mechanism of inhibition in XTP-Ran assays. As 
an initial investigation of this, we carried out immunofluo- 
rescence localization of XTP-Ran in  transport assays in- 
hibited by the addition of GMPPNP. We chose GMPPNP 
for this experiment because it has previously been used in 
studying the accumulation of Ran at the nuclear envelope 
(Melchior et al.,  1995a)  and it is an effective inhibitor in 
XTP-Ran assays (see Fig. 4  C). For comparison, we also 
carried out localization of wild-type Ran under the same 
conditions.  As shown in Fig. 6  d, wild-type Ran accumu- 
lates at the nuclear envelope in the presence of GMPPNP. 
However, in XTP-Ran assays GMPPNP did not lead to ac- 
cumulation of Ran at the nuclear envelope (Fig. 6 h). The 
localization of Ran in these assays was predominantly nu- 
clear, and similar to the control (compare Fig. 6, h  and f). 
As observed in the  flow cytometric transport assays, the 
inhibition  of transport in  assays supported  by XTP-Ran 
was not as extensive as with wild-type Ran. Reduced trans- 
port inhibition per se does not affect Ran accumulation, as 
a  half-maximally inhibiting  concentration  of  GMMPNP 
(25 I~M) still caused strong accumulation of wild-type Ran 
at the nuclear envelope (data not shown). We did not ob- 
serve increased binding of transport ligand at the nuclear 
envelope in any of the inhibited assays, and immunofluo- 
rescence localization of NTF2, hSrpla (NLS receptor), and 
p97 showed no obvious changes in their distribution (data 
not shown). This localization of Ran represents a clear dif- 
ference between the inhibition of transport by nonhydro- 
lyzable GTP analogues in assays containing wild-type ver- 
sus XTP-Ran. It therefore provides further evidence that 
the inhibition of transport observed in XTP-Ran assays is 
mediated by a different GTPase. 
Inhibition Reduces the Rate of Transport and Is Not 
Dependent on the Ratio between Cells and Cytosol 
One reason for obtaining a maximum of 50% inhibition in 
the  XTP-Ran  assays might  be that  the  nonhydrolyzable 
GTP analogues have only an indirect effect on the import 
pathway. If this were the case, it might well be reflected in 
a  delay of the onset of inhibition during the transport as- 
say. To investigate whether any lag period exists, we ex- 
amined the time course of GTP~/S inhibition in transport 
assays containing XTP-Ran (Fig. 7 A) or, for comparison, 
wild-type Ran (Fig. 7 B). As has been demonstrated previ- 
ously (Melchior et al., 1993), GTP~S inhibition of wild-type 
Ran resulted in a  reduction in the rate of transport over 
the entire course of the 30-min assay (Fig. 7  B). Fig. 7 A 
shows that the same was also true for assays supported by 
XTP-Ran, i.e., that in both the presence and absence of in- 
hibitor transport was linear over the 30-min time period 
but in the presence of inhibitor the overall rate of trans- 
port was reduced. The inhibitory effect of GTP~/S in these 
assays was manifest even at the earliest time point, and it 
continuously affected the rate of transport over the entire 
course of the assay. This consistent reduction in the overall 
rate of transport suggests that the GTP~/S has a direct ef- 
fect on one or more components of the nuclear import ma- 
chinery, rather than acting via an indirect mechanism. 
Using this in vitro assay system, nonhydrolyzable GTP 
Sweet and Gerace  GTPases  in Nuclear  Protein Import  977 Figure 5.  Inhibition of transport in XTP-Ran assays is not mediated by Ran. Varying amounts of wild-type and XTP-Ran were added to 
transport assays containing purified transport factors (25 txg/ml hSrplct and 12.5 i~g/ml NTF2) as indicated; the shaded bars represent 
the assays that contained 200 IxM GTP~S. (A) Titration of XTP-Ran. Transport assays containing 0.5-2.5 Ixg of XTP-Ran per assay (fi- 
nal concentrations  12.5-62.5 izg/ml), in comparison to either no Ran (0) or 1 t~g of wild-type Ran, were performed in the absence or 
presence of 200 p,M GTP~/S. (B) Titration of wild-type Ran addition. Different amounts of wild-type Ran, forming a dilution series from 
1 p.g (1) to 0.05 Ixg (1/20), were added to assays containing I  txg of XTP-Ran (25 Ixg/ml) and 200 I~M GTP~/S (shaded bars). The white 
bar represents a control assay containing only 1 Ixg of XTP-Ran. (C) Immunoblot of the wild-type Ran titration. Permeabilized cells 
(P. C., lane 1) and samples of the wild-type Ran dilution series used in B (lanes 3-10) were immunoblotted using anti-Ran antibody. Each 
lane contains 0.5 × the amount present in a transport reaction. 
analogues do not give an irreversible inhibition of trans- 
port (Melchior et al.,  1993; data not shown), so it is not 
possible to determine whether inhibited factors are cell or 
cytosol associated by preincubation with inhibitor.  As an 
alternative  approach to addressing this issue,  we investi- 
gated whether the degree of inhibition in XTP-Ran assays 
is  affected  by  the  ratio  between  ceils  and  cytosol.  We 
chose this method because one of the initial  indications 
that GTP~/S inhibition was mediated by a cytosolic factor 
was the observation that the ratio between cells and cyto- 
sol strongly affected the level of inhibition (Melchior et al., 
1993). We carried out a titration of cytosol addition (using 
cytosol depleted of Ran by column fractionation) in XTP- 
Ran transport assays containing either 2  x  105 or 6 X 105 
permeabilized cells (Fig. 8). Note that this flow cytometric 
assay measures the mean fluorescence per cell, so it gives a 
similar maximal level of transport regardless of the num- 
ber of cells  in the assay. As might be expected, a  higher 
concentration of cytosol was required to give maximal trans- 
port in the assays containing more cells  (Fig. 8 B). How- 
ever, unlike for inhibition of wild-type Ran (Melchior et al., 
1993; data not shown), the number of cells in the assay had 
no effect on the overall level of inhibition obtained. In fact, 
we  found  that  GTP~/S  inhibition  seemed  to  reduce  the 
maximum level of transport that could be reached by the 
cells, irrespective of the concentration of cytosol present in 
the assay. This result was clearest in the assays containing 
6  X  105 cells  (Fig.  8  B) where,  although a  threefold in- 
crease  in  cytosol concentration  (compare 0.31  and  0.94 
mg/ml) gave a  substantial increase in the control level of 
transport, in the presence of GTP~/S there was virtually no 
increase at all. Thus, in XTP-Ran assays, GTP~/S seemed 
to restrict the level of transport that could be attained by 
the permeabilized cells in a way that was neither overcome 
nor  exacerbated  by additional  cytosol. This  observation 
represents  another difference between GTP~/S  inhibition 
in XTP-Ran assays and inhibition mediated by wild-type 
Ran. It also suggests that the inhibited component of the 
transport machinery is a  cell-associated rather than cyto- 
solic factor. 
Discussion 
An XTP-binding Mutant of Ran 
We  have  constructed  and  purified  a  D125N  mutant  of 
Ran,  and  demonstrated  that  this  mutant protein  has  al- 
tered  nucleotide  binding  properties.  As  predicted,  the 
D125N mutation changes the nucleotide binding specific- 
ity of Ran from GTP to XTP and results in a protein that is 
only functional in nuclear protein import in the presence 
of XTP. In fact, in the absence of XTP, D125N Ran (XTP- 
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port by GMPPNP  does not 
lead to accumulation  of Ran 
at  the  nuclear  envelope  in 
XTP-Ran  assays.  Transport 
assays containing  cytosol de- 
pleted  of  Ran  by  column 
fractionation  and  25  o.g/ml 
wild-type  or XTP-Ran were 
incubated for 30 min at 30°C 
in the presence or absence of 
500 IxM GMPPNP. The cells 
were then fixed  and perme- 
abilized, and the Ran was de- 
tected  by  immunofluores- 
cence  microscopy.  Left 
panels  show the localization 
of the FITC-BSA-NLS trans- 
port ligand  and right panels 
show the Ran. 
Ran)  acts as an inhibitor of nuclear protein import (data 
not shown). The reason for this is not clear, but one possi- 
bility is that, like D124N Yptlp (Jones et al., 1995), XTP- 
Ran  sequesters  its  cognate guanine  nucleotide  exchange 
factor RCC1  (Bischoff and Ponstingl,  1991;  Dasso, 1993) 
and  thereby  inhibits  nucleotide  exchange  on  wild-type 
Ran. In the presence of XTP, XTP-Ran appears to func- 
tion in an equivalent manner to wild-type Ran in perme- 
abilized cell nuclear import assays. 
The diversity of GTPases in which a D  to N mutation in 
the G4 domain produces an effective change in nucleotide 
binding  specificity  suggests  that  this  mutation  may  be 
widely applicable within the GTPase superfamily (Hwang 
and Miller,  1987;  Weijland  and Parmeggiani, 1993; Jones 
et al.,  1995;  Kang et al.,  1995;  Powers and Walter,  1995; 
Zhong et al., 1995).  In previous studies, XTP-binding mu- 
tants  have been used to specifically examine the  role  of 
nucleotide  hydrolysis by the  GTPase in  question  (Wiej- 
land  and  Parmeggiani,  1993;  Powers  and  Walter,  1995). 
We have not focused on the role of nucleotide hydrolysis 
by Ran  here,  but XTP-Ran may well be useful for such 
studies in the future, particularly when more purified as- 
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Figure 7.  GTP~S inhibition reduces the rate of nuclear import in 
XTP-Ran  assays. This shows a time course of inhibited nuclear 
import in assays supported by (A) XTP-Ran or (B), for compari- 
son, wild-type Ran. Transport assays containing cytosol depleted 
of Ran by column fractionation  and 25  p.g/ml Ran were incu- 
bated at 30°C for the indicated times then stopped by transfer to 
an ice-water bath and dilution with ice-cold transport buffer (see 
Materials and Methods). The open circles represent  assays that 
contained 200 IxM GTP~/S, and the closed circles represent  con- 
trols that did not. 
O  5  10  15  20 
I~1 cytosol 
Figure 8.  Inhibition by GTP-fS is not influenced by the ratio be- 
tween permeabilized cells and cytosol in XTP-Ran  assays. This 
shows a comparison of the effect of GTP-/S on transport  assays 
containing either 2 × 105 (A) or 6 × 10  s (B) permeabilized cells. 
1 p,g of XTP-Ran (25 p,g/ml), between 0 and 1.25 mg/ml cytosol 
depleted  of Ran by column fractionation  and  the  appropriate 
number of permeabilized ceils were added to each assay (final vol 
40 I~1) in the presence or absence of 200 ~M GTP-/S. 
says that represent either part or all of the nuclear import 
pathway are developed. In this study we have instead used 
the XTP-binding mutant in a novel way, to "bypass" Ran- 
mediated inhibition of nuclear import. This approach is of 
potentially general application, and could be used in charac- 
terization of other intracellular pathways in which GTPases 
are involved. 
A  Second GTPase in Nuclear Protein Import 
The overall aim of this study was to use the XTP-Ran mu- 
tant to investigate whether any additional GTPases are in- 
volved in nuclear protein import. This was carried out by 
replacing wild-type Ran in in vitro assays with XTP-Ran, 
which, as a result of its altered nucleotide binding specific- 
ity, is no longer sensitive to inhibition by nonhydrolyzable 
GTP analogues such as GTP3,S.  Using these XTP-Ran as- 
says, we were able to test whether any components of the 
nuclear import machinery other than Ran are sensitive to 
inhibition by GTP analogues. We found that nonhydrolyz- 
able analogues of GTP, such as GTP~/S and GMPPNP, in- 
hibit  nuclear  import  in  XTP-Ran  assays by  ~50%.  We 
therefore conclude that at least one additional GTPase is 
involved in the nuclear import pathway. 
Blocking GTP hydrolysis by Ran has a potent inhibitory 
effect  on  nuclear  import  (Melchior  et  al.,  1993,  1995a; 
Moore and Blobel, 1993; this study), so it was important to 
clearly establish that the inhibition in XTP-Ran assays is 
not in fact due to Ran. There are two potential sources of 
Ran-mediated inhibition: the XTP Ran itself and the trace 
amount of wild-type Ran that remains in the permeabil- 
ized cells and depleted cytosol. Several experiments in this 
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the XTP-Ran nor residual wild-type Ran are responsible 
for the inhibition observed. 
If the inhibition were mediated by XTP-Ran, it would 
involve unexpected binding of the GTP analogues by the 
mutant protein. In EDTA-based exchange assays, XTP- 
Ran has a much higher affinity for XTP than GTP, GTP~S, 
or ATP and is therefore unlikely to bind to GTP~S in the 
transport assays, which contain 1 mM XTP and ATP. The 
inhibitor dose-response curves suggest that the inhibition 
involves  a  high  affinity interaction  with  a  protein  that 
shows  similar sensitivity to the  GTP analogues as wild- 
type Ran. From the nucleotide binding studies, this does 
not seem to be the case for XTP-Ran. Increasing the con- 
centration of XTP-Ran did not increase the level of inhibi- 
tion which, bearing in mind the dominant effect of inhib- 
ited  Ran,  might  be  expected to  occur if the  XTP-Ran 
bound to the GTP analogues. Inhibitor-bound XTP-Ran 
would also be expected to accumulate at the nuclear enve- 
lope like wild-type Ran, but no accumulation of Ran was 
detected in the XTP-Ran assays. Finally, the ratio between 
cells and cytosol did not affect the level of inhibition in the 
XTP-Ran assays, whereas Ran-mediated inhibition in con- 
ventional transport assays (Melchior et al., 1993) or assays 
containing recombinant wild-type Ran  (data not shown) 
was  substantially  reduced  by  increasing  the  number  of 
cells in  the  assay.  Taken together, these results provide 
strong evidence that GTP~/S inhibition of nuclear import 
in XTP-Ran assays is not mediated by XTP-Ran. 
The lack of Ran accumulation at the nuclear envelope 
and independence from the cetl/cytosol ratio also provide 
evidence that the residual wild-type Ran is not responsible 
for the inhibition observed, as they represent clear differ- 
ences between the inhibition in XTP-Ran assays and that 
mediated by wild-type Ran. In addition, if the intermedi- 
ate level of inhibition in XTP-Ran assays were due to a 
competition between XTP-Ran and residual wild-type Ran 
bound to inhibitor, increasing the concentration of XTP- 
Ran would be expected to relieve the inhibition, but this 
did not occur. As wild-type Ran has a dominant inhibitory 
effect in these in vitro assays, we were able to test directly 
whether the residual wild-type Ran could account for the 
inhibition using a titration of wild-type Ran addition. This 
experiment showed that the amount of Ran that needed to 
be added  to increase  the  level of inhibition was  signifi- 
cantly greater than the amount already present, demon- 
strating that the residual Ran present is not sufficient to 
cause the inhibition observed. Thus, it is highly unlikely 
that inhibition of nuclear import in XTP-Ran assays by 
nonhydrolyzable GTP analogues  is  caused  by the  trace 
amount of wild-type Ran that remains in the assay. 
As well as substantiating the evidence that the inhibition 
is mediated by a factor other than Ran, the characteristics 
of the inhibitory effect provide some initial insights into 
the mechanism involved. The consistent reduction in the 
rate of transport over the course of the 30-rain assays sug- 
gests that the inhibited component is directly involved in 
the nuclear import pathway. Increasing the concentration 
of cytosol in the assay was not able to overcome the inhibi- 
tion, also arguing that it does not result from a defect in re- 
cycling of cytosolic transport factors. Also, the similarity 
of the dose-response curve to that of many GTPases, in- 
cluding Ran  (this study; Melchior et al.,  1993), suggests 
that  the  inhibited  factor is  a  protein  which  specifically 
binds to GTP, i.e., a GTPase, rather than, for example, a 
kinase  with  relatively  promiscuous  nucleotide  binding 
properties such as casein kinase II (Allende and Allende, 
1995). 
An obvious difference between the wild-type and XTP- 
Ran assays is in the overall level of inhibition caused by 
GTP-¢S:  a  maximum of 50--60%  in the XTP-Ran assays 
and 80-90% with wild-type Ran (Melchior et al., 1993; this 
study). Obtaining only ~50%  inhibition by nonhydrolyz- 
able  GTP analogues  in  GTPase-dependent processes is 
not unusual, and has been observed in a number of previ- 
ous studies, e.g., GTP~/S inhibition of vacuolar inheritance 
(Conradt et al.,  1994), endosome fusion (Lenhard et al., 
1992; Spiro et al., 1995), and coated pit invagination and 
budding (Carter et al., 1993). The reason for the partial in- 
hibition obtained in this study is not yet dear, but there 
are a  number of possible explanations. One of the most 
straightforward could be that the second GTPase plays an 
indirect role in the import process. However, as discussed 
above, the rapid onset of the inhibition suggests that this is 
not the case.  Alternatively, there could be an  exchange 
factor acting on the GTPase in the transport assays, mak- 
ing the inhibition to some extent reversible. If the activity 
of the GTPase in transport is not normally rate limiting, 
this could lead to an incomplete level of inhibition. An- 
other possibility is that there are two pathways for nuclear 
import downstream of Ran, only one of which is inhibited 
by nonhydrolyzable GTP analogues.  Clarification of the 
significance of this result will require more detailed char- 
acterization of both the nuclear import pathway and more 
specifically the role of GTPases. 
Several lines  of evidence point  towards  the  inhibited 
GTPase being cell associated rather than cytosolic. Per- 
haps the strongest of these is that we observed a similar 
degree of inhibition in transport assays reconstituted with 
purified transport factors as in those that contained Ran- 
depleted eytosol. If the inhibition were due to a  soluble 
component one would expect it to be present in cytosol 
and to affect the level of inhibition when added. A second 
indication comes from the observation that the degree of 
inhibition was  not influenced by the ratio between ceils 
and cytosol in the assay. In this experiment, it seemed that 
GTP~/S reduced the level of transport that could be reached 
by the permeabilized cells irrespective of the concentration 
of cytosolic factors present. This suggests that, under GTP~S 
inhibition conditions, the rate-limiting step in transport in 
XTP-Ran assays is defined by a cell-associated component 
of the  transport  machinery.  Fractionation of cytosol by 
molecular sieving and ion exchange chromatography has 
also not revealed any cytosolic factors other than Ran that 
specifically modulate GTP~/S inhibition in XTP-Ran assays 
(Sweet, D.J., and L. Gerace, unpublished observations). 
A cell-associated GTPase that is directly involved in nu- 
clear import  would  most  likely be  a  component of the 
NPC. None of the nucleoporins that have been character- 
ized  so  far  contain  a  GTP-binding  domain  (Rout  and 
Wente, 1994; Davis, 1995), although the 60- and 20-30-kD 
nuclear envelope-associated GTP-binding proteins identi- 
fied by GTP overlay and photoaffinity labeling could be 
NPC  proteins  (Rubins  et al.,  1990;  Seydel and  Gerace, 
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ficult to make  comparisons  between nuclear import and 
other translocation processes.  Nevertheless,  it is interest- 
ing that GTPases are involved in the transport of proteins 
across at least two more intracellular membranes. The role 
of GTP hydrolysis in protein translocation into the ER has 
been well documented, and shown to involve the activity of 
several soluble and membrane-associated GTPases (Walter 
and Johnson, 1994). In this case, the membrane-associated 
GTPases (SRP receptor) are thought to act catalytically in 
targeting  and  formation  of  the  translocation  complex 
rather than being involved in translocation itself. Chloro- 
plasts also contain GTPases that are localized to the pro- 
tein translocation site (Kessler et al., 1994; Seedorf et al., 
1995). The functions of these proteins have not been char- 
acterized in detail, but they are thought to form part of the 
translocation  pore  (Schnell  et  al.,  1994;  Seedorf  et  al., 
1995)  and may  also  be  involved in targeting of translo- 
cated proteins to the chloroplast surface (Schnell, 1995). 
What might be the role of an NPC-associated GTPase in 
nuclear import? One model is that it would act in an anal- 
ogous way to Ran, and promote movement of the receptor 
complex along a later part of the transport pathway (Mel- 
chior et al., 1995). However, it could also have a somewhat 
different  function, such as regulating the opening of the 
central  gated  channel.  GTPases  are  generally  viewed  as 
having two conformational states, GTP and GDP bound, 
with interconversion between the two states determining 
the activity and interactions of the protein (Bourne et al., 
1991; Nuoffer and Balch, 1994). A  conformational change 
induced by GTP hydrolysis (or GTP/GDP exchange) could 
act  as  a  trigger  for  opening  of  the  gated  channel  and 
thereby facilitate passage of the receptor complex into the 
nucleus. Clarification of the potential role of GTP hydrol- 
ysis in central channel gating, and regulation of other trans- 
port steps, will require more detailed characterization of 
both the structure  of the nuclear pore  complex  and the 
mechanism of transport across it. 
In summary, we have made use of a mutant form of Ran 
that binds to XTP instead of GTP to investigate whether 
any additional GTPases are involved in the nuclear import 
pathway. Our results have shown that the transport ma- 
chinery does indeed contain a second GTPase,  which we 
speculate  may be associated  with the nuclear pore com- 
plex. Purification and characterization of the GTPase that 
mediates  this inhibitory effect will shed more light on its 
relationship to the NPC and its role in the nuclear import 
process. 
We  are grateful  to Frauke  Melchior  for providing  anti-Ran  antibodies, 
Rohit Mahajan for purified RanBP1, and Tianhua Hu for purified p97 and 
hSrplot. We would also like to thank Frauke Melchior and Bryce Paschal 
for helpful comments on the manuscript, and all the members of the Ger- 
ace laboratory for stimulating discussions. 
This  study  was supported  by grants  from  the  National  Institutes  of 
Health and Human Frontiers Science Program (to L  Gerace) and a SERC- 
NATO (United Kingdom) postdoctoral fellowship (to D. Sweet). 
Received for publication  1 December 1995 and in revised form 21 Febru- 
ary 1996. 
References 
Allende, J.E., and C.C. Allende. 1995. Protein kinases. 4. Protein kinase CK2: an 
enzyme with multiple substrates and a puzzling  regulation. FASEB J. 9:313-323. 
Adam, S.A., R.E. Sterne-Mart,  and L. Gerace. 1990. Nuclear protein import in 
permeabilized mammalian cells requires soluble cytoplasmic factors. J. Cell 
Biol. 111:807--816. 
Adam, S.A., and L. Gerace. 1991. Cytosolic proteins that specifically bind nu- 
clear location signals are receptors for nuclear import. Cell 66:837-847. 
Adam, EJ.H., and S.A. Adam. 1994. Identification of cytosolic factors required 
for nuclear location sequence-mediated  binding to the nuclear envelope. J. 
Cell Biol. 125:547-555. 
Bischoff, F.R.,  and  H.  Ponstingl.  1991. Catalysis of guanine  nucleotide  ex- 
change on Ran by the mitotic regulator RCC1. Nature (Lond.). 354:80-82. 
Bischoff, F.R., H. Krebber, E. Smirnova, W. Dong, and H. Ponstingl. 1995. Co- 
activation of RanGTPase  and inhibition of GTP dissociation by Ran-GTP 
binding protein RanBP1. EMBO (Eur. Mol. Biol. Organ.) J. 14:705-715. 
Bourne, H.R., D.A. Sanders, and F. McCormick. 1991. The GTPase superfamily: 
conserved structure and molecular mechanism. Nature (Lond.). 349:117-127. 
Carter, L.L., T.E. Redelmeier, L.A. Woolenweber, and S.L Schmid. 1993. Mul- 
tiple GTP-binding proteins  participate  in clathrin-coated  vesicle-mediated 
endocytosis. J. Cell Biol. 120:37--45. 
Chi, N.C., E.J.H. Adam, and S.A. Adam. 1995. Sequence and characterization 
of cytoplasmic nuclear protein import factor p97. J. Cell Biol. 130:265-274. 
Conradt, B., A. Haas, and W. Wickner. 1994. Determination  of four biochemi- 
cally distinct sequential  stages during vacuole inheritance  in vitro. J.  Cell 
Biol. 126:99-110. 
Coutavas, E., M.  Ren,  J.D.  Oppenheim,  P.D. D'Eustachio,  and M.G. Rush. 
1993. Characterization  of proteins that interact with the cell-cycle regulatory 
protein Ran/TC4. Nature (Lond.). 366:585-587. 
Dabauvalle, M.-C., R. Benavente, and N. Chaly. 1988a. Monoclonal antibodies 
to a Mr 68,000 pore complex glycoprotein interfere  with nuclear protein up- 
take in Xenopus oocytes. Chromosoma (Berl.). 97:193-197. 
DabauvaUe, M.-C., B. Schulz, U. Scheer, and R. Peters. 1988b. Inhibition of nu- 
clear accumulation of karyophilic proteins in living cells by microinjection of 
the lectin wheat germ agglutinin. Exp. Cell Res. 174:291-296. 
Dasso, M. 1993. RCC1 in cell cycle: the regulator of chromosome condensation 
takes on new roles. Trends Biochem. Sci. 18:96-101. 
Davis, L.I. 1995. The nuclear pore complex. Annu. Rev. Cell Biol. 64:865-896. 
Dingwall, C.,  and  R. Laskey.  1991. Nuclear  targeting  signals---a consensus? 
Trends Biochem. Sci. 16:478-481. 
Enekel,  C., G. Blobel, and M. Rexach.  1995. Identification  of a yeast karyo- 
pherin heterodimer that targets import substrate to mammalian nuclear pore 
complexes. J. Biol. Chem. 270:16499-16502. 
Fabre, E., and E. Hurt.  1994. Nuclear transport.  Curr.  Opin.  Cell Biol. 6:335- 
342. 
Featherstone,  C.M., M.K. Darby, and L. Gerace. 1988. A monoclonal antibody 
against the  nuclear  pore complex inhibits  nucleocytoplasmic transport of 
both protein and RNA in vivo. J. Cell Biol. 107:1289-1297. 
Finlay, D.R., D.D. Newmeyer, T.M. Price, and D.J. Forbes. 1987. Inhibition of 
in vitro nuclear transport by a lectin that binds to nuclear pores. J. Cell Biol. 
104:189-200. 
G/Srlich, D., S. Prehn, R.A. Laskey, and E. Hartmann.  1994. Isolation of a pro- 
tein that is essential for the first step of nuclear protein import. Cell. 79:767- 
778. 
Gtrlich, D., S. Kostka, R. Kraft, C. Dingwall, R.A. Laskey, E. Hartmann,  and 
S. Prehn.  1995. Two different subunits of importin cooperate  to recognize 
nuclear  localization signals and  bind them to the  nuclear envelope.  Curr. 
Biol. 5:383-392. 
Holt, G.D., C.M. Snow, A. Senior, R.S. Haltiwanger, and L. Gerace. 1987. Nu- 
clear  pore  complex  glycoproteins  containing  cytoplasmically  disposed 
O-linked N-acetylglucosamine. J. Cell Biol. 104:291-308. 
Hwang, Y.-W., and D. Miller. 1987. A mutation that alters the nucleotide speci- 
ficity of elongation factor Tu, a GTP regulatory protein. Z Biol. Chem. 262: 
13081-13085. 
Imamoto, N., Y. Matsuoka, T. Kurihara, K. Kohno, M. Miyagi, F. Sakiyama, Y. 
Okada, S. Tsunasawa, and Y. Yoneda. 1992. Antibodies against 70-kD heat 
shock cognate protein  inhibit mediated  nuclear import of karyophilic pro- 
teins. J. Cell Biol. 119:1047-1061. 
Imamoto, N., T. Shimamoto, S. Kose, T. Takao, T. Tachibana, M. Matsubae, T. 
Sekimoto, Y. Shimonishi, and Y. Yoneda. 1995a. The nuclear pore-targeting 
complex binds to nuclear pores after  association with a karyophile. FEBS 
LETT. 368:415-419. 
Imamoto, N., T. Shimamoto, T. Takeo, T. Tachibana, S. Kose, M. Matsubae, T. 
Sekimoto, Y. Shimonishi, and Y. Yoneda.  1995b. In vivo evidence for in- 
volvement of a 58 kDa component of the nuclear-pore targeting complex in 
nuclear protein import. EMBO (Eur. Mol. Biol. Organ.) J. 14:3617-3626. 
Jones, S., R.J. Litt, C.J. Richardson, and N. Segev. 1995. Requirement  of nude- 
otide exchange factor for Yptl GTPase mediated  protein transport.  J.  Cell 
Biol. 130:1051-1061. 
Kang, C., N. Sun, R.B. Hontzatko,  and  H.J.  Fromm.  1995. Replacement  of 
Asp333 with Asn by site-directed mutagenesis changes the substrate specific- 
ity of Escherichia coli adenylosuccinate  synthetase  from guanosine  5'-tri- 
phosphate to xanthosine 5'-triphosphate.  J. Biol. Chem. 269:24046-24049. 
Kessler, F., G. Blobel, H.A. Patel, and D.J. Schnell. 1994. Identification of two 
GTP-binding proteins in the chloroplast protein  import machinery. Science 
(Wash. DC). 266:1035-1039. 
Kunkel, T.A., J.D. Roberts,  arid R.A. Zakour.  1987. Rapid and efficient site- 
specific mutagenesis without phenotypic selection. Methods  Enzymol.  154: 
The Journal of Cell Biology, Volume 133, 1996  982 367-382. 
Lenhard,  J.M., R.A. Kahn, and P.D. Stahl. 1992. Evidence for ADP-ribosyla- 
tion factor (ARF) as a regulator  of in vitro endosome-endosome fusion. J. 
Biol. Chem. 267:13047-13052. 
Manne, V., S. Yamazaki, and H-F. Kung. 1984. Guanosine  nucleotide binding 
by highly purified Ha-ras-encoded p21 protein produced in Escherichia coli. 
Proc. Natl. Acad. Sci.  USA. 81:6953--6957. 
Melchior, F., B. Paschal, J. Evans, and L. Gerace.  1993. Inhibition of nuclear 
protein import by nonhydrolyzable analogues of GTP and identification of 
the small GTPase Ran/TC4 as an essential transport factor. Z Cell Biol. 123: 
1649-1659. 
Melchior, F., and L. Gerace. 1995. Mechanisms of nuclear protein import. Curr. 
Opin. Cell Biol. 7:310-318. 
Melchior, F., T. Guan, N. Yokoyama, T. Nishimoto, and L. Gerace. 1995a. GTP 
hydrolysis by Ran occurs at the nuclear pore complex in an early step of pro- 
tein import. J. Cell Biol. 131:571-581. 
Melchior, F., D.J. Sweet, and L. Gerace.  1995b. Analysis of Ran/TC4 function 
in nuclear protein import. Methods Enzymol. 257:279-291. 
Moore,  M.S., and  G. Blobel. 1993. The GTP-binding  protein  Ran/TC4  is re- 
quired for protein import into the nucleus. Nature (Lond.). 365:661-663. 
Moore, M.S., and G. Blobel. 1994. Purification of a Ran-interacting protein that 
is required  for protein import into the nucleus. Proc. Natl. Acad. Sci.  USA. 
91:10212-10216. 
Moroianu, J., G. Blobel, and A. Radu.  1995a. Previously identified protein  of 
uncertain function is karyopherin  a and together  with karyopherin  13 docks 
import substrate at nuclear pore complexes. Proc. Natl. Acad. Sci.  USA. 92: 
2008-2011. 
Moroianu, J., M. Hijikata, G. Blobel, and A. Radu. 1995b. Mammalian karyo- 
pherin alb and a2b heterodimers:  al and a2 subunit binds nuclear localiza- 
tion signal and b subunit interacts with peptide repeat-containing  nucleopor- 
ins. Proc. Natl. Acad. Sci.  USA. 92:6352-6356. 
Nuoffer, C., and W. Balch. 1994. GTPases: multifunctional molecular switches 
regulating vesicular traffic. Annu. Rev. Biochem. 63:949-990. 
Paine, P.L., L.C. Moore, and S.B. Horowitz. 1975. Nuclear envelope permeabil- 
ity. Nature (Lond.). 254:10%114. 
Pantt, N., and U. Aebi. 1994. Toward the molecular details of the nuclear pore 
complex. J. Struct. Biol. 113:179-189. 
Paschal, B.M., and L. Gerace.  1995. Identification  of NTF2, a cytosolic factor 
for nuclear import that interacts with nuclear pore complex protein p62. J. 
Cell Biol. 129:925-937. 
Peters,  R.  1986. Fluorescence  microphotolysis to measure  nucleocytoplasmic 
transport and intracellular mobility. Biochim. Biophys. Acta. 864:31)4-369. 
Powers, T., and P. Walter. 1995. Reciprocal stimulation of GTP hydrolysis by 
two directly interacting GTPases. Science (Wash. DC). 269:1422-1424. 
Radu, A., G. Blobel, and M.S. Moore. 1995. Identification of a protein complex 
that is required  for nuclear protein  import and mediated docking of import 
substrate to distinct nucleoporins. Proc. Natl. Acad Sci.  USA. 92:176%1773. 
Rout,  M.P., and S.R. Wente.  1994. Pores  for thought: nuclear  pore complex 
proteins. Trends Cell Biol. 4:357-365. 
Rubins, J.B., J.O. Benditt, B.F. Dickey, and N. Riedel. 1990. GTP-binding pro- 
teins in rat liver nuclear  envelopes.  Proc.  Natl.  Acad.  Sci.  USA.  87:7080- 
7084. 
Schnell, D.J. 1995. Shedding light on the chloroplast protein import machinery. 
Cell. 84:521-524. 
Schnell DJ., F. Kessler, and G. Blobel. 1994. Isolation of components  of the 
chloroplast protein import machinery. Science (Wash. DC) 266:1007-1012. 
Seedorf, M., K. Waegemann, and J. SoIL 1995. A constituent of the chloroplast 
import complex represents  a new type of GTP-binding protein.  Plant J. 7: 
401--411. 
Seydel, U., and L. Gerace.  1991. A 28,000-Da GDP/GTP-binding  protein  spe- 
cific to the nuclear envelope. J. Biol. Chem. 266:7602-7608. 
Shi, Y., and J.O. Thomas. 1992. The transport of proteins  into the nucleus re- 
quires 70 kDa heat shock protein or its cytosolic cognate. Mol. Cell. Biol. 12: 
2186-2192. 
Spirt, D.J., T.C. Taylor, P. Melancon, and M. Wessling-Resnick. 1995. Cyto- 
solic ADP-ribosylation factors are not required for endosome-endosome  fu- 
sion but are  necessary for GTPS inhibition  of fusion. J.  Biol.  Chem.  270: 
13693-13697. 
Walter  P., and A.E. Johnson. 1994. Signal sequence  recognition  and protein 
targeting to the endoplasmic reticulum membrane. Annu~ Rev. Cell Biol. 10: 
87-119. 
Weis, K., I.W. Mattaj,  and A.I. Lamond.  1995. Identification  of hSrpla as a 
functional receptor for nuclear localization sequences. Science (Wash. DC). 
268:1049-1053. 
Wiejland, A., and A. Parmeggiani. 1993. Toward a model of the interaction be- 
tween  elongation  factor  Tu and  the  ribosome.  Science  (Wash.  DC).  259: 
1311-1314. 
Wu, J, M.J. Matunis, D. Kraemer, G. Blobel, and E. Coutavas. 1995. Nup358, a 
cytoplasmically exposed nucleoporin with peptide repeats, Ran-GTP binding 
sites, zinc fingers, a cyclophilin A homologous domain, and a leucine-rich re- 
gion. J. Biol. Chem. 270:1420%14213. 
Yano, R., M. takes, M. Yamagashi, J.A. Dodd, and M. Nomura. 1992. Cloning 
and characterization  of SRP1, a suppressor of temperature  sensitive RNA 
polymerase  I mutations,  in Saccharomyces  cerevisiae.  Mol.  Cell.  Biol.  12: 
5640-5651. 
Yokoyama, N., N. Hiyashi, T. Seki, N. Pante, T. Ohba, K. Nishli, K. Kuma, T. 
Hayashida, T. Miyata, U. Aebi et al. 1995. RanBP2, a gigantic nuclear pore 
complex protein that has Zn2+ fingers, a cyclophilin domain and binds Ran/ 
TC4. Nature (Lond.). 376:184-188. 
Yoneda, Y., N. Imamoto-Sonobe, M. Yamaizumi, and T. Uchida. 1987. Revers- 
ible inhibition of protein import into the nucleus by wheat germ agglutinin 
injected into tissue culture cells. Exp. Cell. Res. 173:586-595. 
Zhong, J.-M., M.-C. Chen-Hwang, and Y.-W. Hwang. 1995. Switching nucle- 
otide specificity of Ha-Ras p21 by a single amino acid substitution  at aspar- 
tate 119. J. Biol. Chem. 270:10002-10007. 
Sweet and Gerace GTPases in Nuclear Protein Import  983 